Huntington's disease repeat instability and pathogenesis
亨廷顿病重复不稳定性和发病机制
基本信息
- 批准号:9027108
- 负责人:
- 金额:$ 58.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAge of OnsetAutopsyBrainBrain regionCAG repeatCell DeathCell LineageCellsChromosomes, Human, Pair 3ClinicalClustered Regularly Interspaced Short Palindromic RepeatsCognitiveCorpus striatum structureDNA RepairDNA Repair GeneDNA Repair PathwayDNA Sequence AlterationDataDiseaseEmotionalEnhancersExhibitsGene ExpressionGene-ModifiedGenerationsGenesGeneticGenetic VariationGenotypeGuide RNAHealth Care CostsHumanHuman GenomeHuntington DiseaseInheritedKnock-in MouseLengthLiverLong-Term CareMLH1 geneMediatingMicroRNAsMismatch RepairModificationMolecularMotorMusMutationNeurodegenerative DisordersNeuronsNuclearOnset of illnessOutcomePathogenesisPathway interactionsPatientsPhenotypeProcessRad30 proteinRecruitment ActivityRoleSourceSpecificitySymptomsTestingTherapeutic InterventionTimeTissuesVariantadeno-associated viral vectorbasedisease phenotypeeffective therapyendonucleasegenetic approachgenome wide association studyhuman Huntingtin proteinhuman datain vivoinduced pluripotent stem cellinsightintergenerationalknock-downlymphoblastoid cell linemouse modelmutantnovelpublic health relevanceresearch studytherapeutic developmenttherapeutic targettransmission process
项目摘要
DESCRIPTION (provided by applicant)
Huntington's disease (HD) is a devastating and fatal neurodegenerative disorder caused by the expansion of a polymorphic CAG repeat in the HTT gene that triggers cell death with a specificity towards neurons in the striatum and cortex. Although the underlying genetic mutation was discovered over 20 years ago, there is still no cure or effective treatment despite extensive efforts. The HTT CAG repeat mutation is highly unstable both in transmissions to subsequent generations and somatically. Notably the repeat undergoes dramatic tissue-specific somatic expansion, particularly in the brain regions affected in the disorder, strongly suggesting that somatic HTT CAG length increases in target tissues contribute to HD pathogenesis. We have shown in accurate genetic HD knock-in mouse models that genes in the mismatch repair (MMR) pathway (Msh2, Msh3, Mlh1, Mlh3) are critical for CAG expansion and enhance the pathogenic process. The relevance of these findings to HD patients is indicated by a recent genome-wide association study in which MLH1 SNPs were associated with motor onset, and more generally, in which DNA repair pathways were highlighted as a source of disease modification. In this study we will: 1) perform genetic experiments in HD knock-in mice that will provide insight into mechanism(s) of MMR-dependent instability and pathogenesis; 2) test the impact of MLH1 SNPs in HD patients on gene expression, cellular phenotypes and on somatic and intergenerational repeat instability; 3) Use gene knockdown and gene editing approaches to test the impact of additional DNA repair genes, implicated as disease modifiers in patients, as modifiers of instability and striatal pathogenesis in HD knock-in mice. Together, these experiments will provide critical insight into pathways and mechanisms by which MMR/DNA repair genes modify pathogenesis, which will directly impact on the development of therapeutics that promise to target mechanism(s) that occur very early in the disease process.
描述(由申请人提供)
亨廷顿氏病(HD)是一种毁灭性和致命的神经退行性疾病,由HTT基因中多态性CAG重复序列的扩增引起,其触发细胞死亡,对纹状体和皮质中的神经元具有特异性。虽然潜在的基因突变在20多年前就被发现了,但尽管付出了广泛的努力,仍然没有治愈或有效的治疗方法。HTT CAG重复突变在传递给后代和体细胞方面都是高度不稳定的。值得注意的是,重复经历了显着的组织特异性体细胞扩张,特别是在受疾病影响的脑区域,强烈表明靶组织中的体细胞HTT CAG长度增加有助于HD发病机制。我们已经在精确的遗传HD基因敲入小鼠模型中表明,错配修复(MMR)途径中的基因(Msh 2、Msh 3、Mlh 1、Mlh 3)对于CAG扩增至关重要,并增强了致病过程。最近的一项全基因组关联研究表明这些发现与HD患者的相关性,其中MLH 1 SNP与运动发作相关,更普遍的是,其中DNA修复途径被强调为疾病修饰的来源。在本研究中,我们将:1)在HD敲入小鼠中进行遗传实验,其将提供对MMR依赖性不稳定性和发病机制的深入了解; 2)测试HD患者中MLH 1 SNP对基因表达、细胞表型以及对体细胞和代际重复不稳定性的影响; 3)使用基因敲除和基因编辑方法来测试额外的DNA修复基因的影响,这些基因被认为是患者的疾病修饰因子,作为HD基因敲入小鼠不稳定性和纹状体发病机制的调节剂。总之,这些实验将为MMR/DNA修复基因改变发病机制的途径和机制提供关键的见解,这将直接影响有望靶向疾病过程早期发生机制的治疗方法的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VANESSA C WHEELER其他文献
VANESSA C WHEELER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VANESSA C WHEELER', 18)}}的其他基金
2023 CAG Triplet Repeat Disorders Gordon Research Conference and Seminar
2023年CAG三重重复疾病戈登研究会议暨研讨会
- 批准号:
10682090 - 财政年份:2023
- 资助金额:
$ 58.97万 - 项目类别:
Huntington's Disease Repeat Instability and Pathogenesis
亨廷顿病重复不稳定和发病机制
- 批准号:
8049649 - 财政年份:2005
- 资助金额:
$ 58.97万 - 项目类别:
Huntington's Disease Repeat Instability and Pathogenesis
亨廷顿病重复不稳定和发病机制
- 批准号:
8448749 - 财政年份:2005
- 资助金额:
$ 58.97万 - 项目类别:
Huntington's Disease Repeat Instability and Pathogenesis
亨廷顿病重复不稳定和发病机制
- 批准号:
7237199 - 财政年份:2005
- 资助金额:
$ 58.97万 - 项目类别:
Huntington's Disease Repeat Instability and Pathogenesis
亨廷顿病重复不稳定和发病机制
- 批准号:
7848408 - 财政年份:2005
- 资助金额:
$ 58.97万 - 项目类别:
Huntington's Disease Repeat Instability and Pathogenesis
亨廷顿病重复不稳定和发病机制
- 批准号:
7884690 - 财政年份:2005
- 资助金额:
$ 58.97万 - 项目类别:
Huntington's Disease Repeat Instability and Pathogenesis
亨廷顿病重复不稳定和发病机制
- 批准号:
7082895 - 财政年份:2005
- 资助金额:
$ 58.97万 - 项目类别:
Huntington's Disease Repeat Instability and Pathogenesis
亨廷顿病重复不稳定和发病机制
- 批准号:
8104545 - 财政年份:2005
- 资助金额:
$ 58.97万 - 项目类别:
Huntington's Disease Repeat Instability and Pathogenesis
亨廷顿病重复不稳定和发病机制
- 批准号:
8244952 - 财政年份:2005
- 资助金额:
$ 58.97万 - 项目类别:
Huntington's Disease Repeat Instability and Pathogenesis
亨廷顿病重复不稳定和发病机制
- 批准号:
7426362 - 财政年份:2005
- 资助金额:
$ 58.97万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Determining the mechanism of action of cis-acting modifiers on the age of onset of Huntington Disease
确定顺式作用修饰剂对亨廷顿病发病年龄的作用机制
- 批准号:
417256 - 财政年份:2019
- 资助金额:
$ 58.97万 - 项目类别:
Studentship Programs
Effect of age of onset of contraception use on brain functioning.
避孕开始年龄对大脑功能的影响。
- 批准号:
511267-2017 - 财政年份:2017
- 资助金额:
$ 58.97万 - 项目类别:
University Undergraduate Student Research Awards
Non-random occurrence and early age of onset of diverse lymphoid cancers in families supports the existence of genetic risk factors for multiple lymphoid cancers.
家族中多种淋巴癌的非随机发生和发病年龄较早,支持多种淋巴癌存在遗传危险因素。
- 批准号:
347105 - 财政年份:2016
- 资助金额:
$ 58.97万 - 项目类别:
Polish-German Child Bilingualism: The Role of Age of Onset for Long-Term Achievement
波兰-德国儿童双语:发病年龄对长期成就的作用
- 批准号:
277135691 - 财政年份:2015
- 资助金额:
$ 58.97万 - 项目类别:
Research Grants
Bioinformatics strategies to relate age of onset with gene-gene interaction
将发病年龄与基因间相互作用联系起来的生物信息学策略
- 批准号:
9097781 - 财政年份:2015
- 资助金额:
$ 58.97万 - 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
- 批准号:
9212684 - 财政年份:2014
- 资助金额:
$ 58.97万 - 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
- 批准号:
8696557 - 财政年份:2014
- 资助金额:
$ 58.97万 - 项目类别:
Effects of delaying age of onset of binge drinking on adolescent brain development: A proposal to add neuroimaing measures to the CO-Venture Trial.
延迟酗酒的发病年龄对青少年大脑发育的影响:在 CO-Venture 试验中添加神经影像测量的建议。
- 批准号:
267251 - 财政年份:2012
- 资助金额:
$ 58.97万 - 项目类别:
Operating Grants
Stress Effects on Alcohol Consumption: Age of onset and genes in heavy drinkers
压力对饮酒的影响:酗酒者的发病年龄和基因
- 批准号:
8606722 - 财政年份:2012
- 资助金额:
$ 58.97万 - 项目类别:
Marijuana: Neurobiologic Correlates of Age of Onset
大麻:发病年龄的神经生物学相关性
- 批准号:
8644793 - 财政年份:2012
- 资助金额:
$ 58.97万 - 项目类别: